相关实验视频

Updated: Jan 16, 2026

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions

Published on: December 20, 2017

甲素B激活原药用于精确的瘤治疗术

Wenhao Zhai¹, Jiajun Li¹, Di Zhao¹

¹College of Pharmacy, Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, Key Laboratory of Ningxia Minority Medicine Modernization, Ministry of Education, Ningxia Medical University, Yinchuan 750004, China.

Journal of medicinal chemistry

|October 3, 2025

概括

一种新型的治疗前药物系统,NM-001,通过整合素 α_νβ₃来向瘤. 它释放ambucil,并提供双通道光学反,用于精确监测药物输送和释放.

科学领域:

生物医学工程生物医学工程
纳米技术纳米技术
在瘤学瘤学.

背景情况:

化疗剂会引起全身毒性.
瘤的微环境是多样化的.
需要有针对性的药物输送.

研究的目的:

开发一种创新的治疗前药物系统,NM-001.1.
为了实现有针对性的药物输送和释放.
为监控建立一个双通道的光学反机制.

主要方法:

在使用cRGD的瘤细胞上,NM-001向整合素α_νβ₃.
卡瑟普辛B分裂了GFLG,释放了ambucil (CLB) 并产生了NM-002.2.
从绿色到近红外 (NIR) 的光过渡进行监测.

主要成果:

NM-001对瘤细胞具有很高的选择性.
在体外和体内,NM-001显示出相当大的抗瘤疗效.
双通道光学反能够实时监测药物输送和释放.

结论:

NM-001是一种有前途的治疗前药物系统.
它为个性化癌症诊断和治疗提供了一种新的方法.
双通道反机制允许在细胞水平上进行精确的监控.

更多相关视频

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...